TOP NEWS

MiCardia Gets $9M

Irvine-based MiCardia has raised $9M in a venture funding from HBM Biocapital, Japan Asia Investment Company, Ltd., the MedFocus Family of Funds, the BioStar Private Equity Fund, LLC, and individuals. MiCardia is developing non-invasive and minimally invasive adjustable cardiovascular implants for the treatment of various stages of Congestive Heart Failure ("CHF"). The firm said the funding would enable it to accelerate its development plans. More information »


RELATED COMPANIES


RELATED STORIES

MARKETPLACE

LATEST HEADLINES

More Headlines

BROWSE ISSUES